Ferrell John D. 4/A

What Happened

John D. Ferrell, Executive Vice President — Human Resources at CONMED Corporation (CNMD), was granted 16,926 restricted stock units (RSUs) on March 2, 2026. The award is reported as a derivative grant with a reported acquisition price of $0.00 (i.e., RSUs that convert to shares on vesting). This Form 4/A amends a prior filing to correct the grant amount — an additional special award of 7,644 RSUs was added to the originally reported 9,282 RSUs for a total of 16,926.

Key Details

• Transaction date: 2026-03-02 (reported on amended Form 4 filed 2026-03-18).
• Transaction type: Award/Grant of RSUs (derivative) — 16,926 RSUs, $0.00 per unit reported.
• Vesting: RSUs are governed by CONMED’s 2025 Long-Term Incentive Plan; generally vest over three years (≈33% after year 1, 33% after year 2, 34% after year 3). (Footnote F1)
• Amendment reason: This Form 4/A corrects the RSU amount — originally 9,282 RSUs were reported; an additional 7,644 RSUs were included for the total of 16,926. (Footnote F2)
• Shares owned after transaction: Not specified in the information provided on this amendment.
• Filing timeliness: The Form 4 was amended and filed 16 days after the transaction date; this is a correcting/amended filing and not a same‑day original Form 4 submission.

Context

• RSUs are a form of compensation (not an open‑market purchase or sale). They represent a contingent right to receive common stock if and when they vest; no cash changed hands at grant.
• Grants to executives are common and typically reflect compensation/retention practices; they do not inherently signal a buy or sell decision by the insider.
• Because this filing is an amendment correcting the grant amount, it’s primarily administrative — investors should track vesting and any future Form 4s showing conversion to shares or subsequent sales.